share_log

Inhibikase Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Milton H. Werner(19.68%)

Inhibikase Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Milton H. Werner(19.68%)

2023/02/15 19:45
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息